Trials / Recruiting

RecruitingNCT06450080

Study of the Relationship Between Clinical, Imaging and Biological Data in Patients With Squamous Cell Carcinoma of the Tongue

Status: Recruiting
Phase: N/A
Study type: Interventional
Enrollment: 60 (estimated)

Sponsor: Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex: All
Age: 18 Years
Healthy volunteers: Accepted

Summary

Squamous cell carcinoma (SCC) could be a very aggressive cancer and has a bad prognosis if not detected early and thus is associated with high mortality. The development of simple and reliable biomarkers for the early detection of SCC is one of the solutions to better diagnose, treat these tumors, evaluate and monitor treatments, and hence reduce mortality. In a previous work, the investigators demonstrated the ability of Proton Magnetic resonance spectroscopy (1H-MRS) to non-invasively assess spectroscopic and metabolic profiles of tongue tissue in healthy subjects. In the present work, the investigators challenge the use of in-vivo 1H-MRS as a potential method for non-invasive metabolic monitoring of patients with squamous cell carcinoma of the tongue undergoing therapy. Thus the main objective is to study the spectroscopic and metabolic differences, e.g. including variation in the metabolite TMA-Cho (trimethylamine-choline), of tongue tissue between healthy subjects and in patients with squamous cell carcinoma of the tongue, before and after surgery.

Conditions

Interventions

Type	Name	Description
OTHER	MRI and MRS acquisitions	All MRI and MRS acquisitions for this study will be carried out on the GIE Faire Faces ACHIEVA 3T TX DStream Philips® Research MRI using a 32-channel head antenna located at the Amiens-Picardie University Hospital .

Timeline

Start date: 2024-03-27
Primary completion: 2026-03-01
Completion: 2026-06-01
First posted: 2024-06-10
Last updated: 2024-06-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06450080. Inclusion in this directory is not an endorsement.